ClinicalTrials.Veeva

Menu

Prospective Single-center Long-term Follow-up Study of a Series of Cases Previously Included in the QUALVIDON Study (QUALVIDON2)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Dry Eye
Neuropathic Pain

Treatments

Procedure: Bilateral ophthalmologic examination
Other: Self-administered questionnaires

Study type

Observational

Funder types

NETWORK

Identifiers

NCT05523531
SDN_2022_7

Details and patient eligibility

About

Dry eye affects millions of people around the world. Some dry eye patients complain of neuropathic eye pain that can affect their quality of life.

From August 2016 to June 2017, the QUALVIDON study (NCT03296111), conducted at the Adolphe de Rothschild Foundation Hospital, assessed pain and its impact on quality of life using self-administered questionnaires in a series of dry eye patients. This 2nd study, entitled QUALVIDON2, focuses on the outcome of patients previously included in QUALVIDON.

Enrollment

14 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients previously included in the QUALVIDON study with the following characteristics:
  • With characteristics of idiopathic neuropathic eye pain associated with dry eye
  • Give informed consent
  • Affiliated or beneficiary of the french social security

Exclusion criteria

  • Pregnant or nursing woman
  • Patient under legal protection

Trial design

14 participants in 1 patient group

Patients with characteristics of idiopathic neuropathic eye pain associated with dry eye
Description:
Previously included in the QUALVIDON study
Treatment:
Procedure: Bilateral ophthalmologic examination
Other: Self-administered questionnaires

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems